ειξτθ 10 ξ"β/ξ"μ
|
|
ων δϊψετδ αΰπβμιϊ: Vimpat 10 Mg/ml.
ξητωιν ϊψετδ ΰηψϊ? λπρε μΰιπγχρ δϊψετεϊ »
|
|
 αρμ δαψιΰεϊ
φεψϊ ξϊο
I.V
ξιπεο
Solution For Infusion
ωιξεω αϊψετδ
Vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.Vimpat solution for infusion is an alternative for patients when oral administration is temporary not feasible.
ξρτψ ψιωεν
149 13 33552 00
ιφψο
Ucb Pharma S.a., Belgium
ϊεχσ ψιωιεο μϊψετδ
01/2013 - 12/2017
|
ηεξψ τςιμ
|
ψιλεζ / λξεϊ αιηιγϊ ξιπεο
|
| Lacosamide |
10 MG / 1 ML |
|
ΰψιζδ
|
λξεϊ αΰψιζδ
|
ηιι ξγσ
|
ϊψετϊ ξψων
|
| Vial glass type i |
1 x 20 ML |
ηεγωιν 36 |
λο |
| Vial glass type i |
5 x 20 ML |
ηεγωιν 36 |
λο |
|
|
|
|
